Skip to main content
Erschienen in: The Journal of Headache and Pain 1/2015

Open Access 01.12.2015 | Invited speaker presentation

The costs of headache disorders

verfasst von: Francesco Saverio Mennini, Lara Gitto

Erschienen in: The Journal of Headache and Pain | Sonderheft 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
The impact of headache disorders is a problem of enormous proportions, both for the individual and the society. Medical literature has tried to assess its effects on individuals, by examining prevalence, distribution, attack frequency and duration, and headache-related disability, as well as effects on society, looking at the socio-economic burden of headache disorders.
The issue of costs represents an important problem too, concerning both direct and indirect costs. Direct costs concern mainly expenses for drugs.
Migraine has a considerable impact on functional capacity, resulting in disrupted work and social activities: many migraineurs do not seek medical attention because they have not been accurately diagnosed by a physician or do not use prescribed medication[1].
Indirect costs associated with reduced productivity represent a substantial proportion of the total cost of migraine as well. Migraine has a major impact on the working sector of the population, and therefore, determining the indirect costs outweighs the direct costs. This study will explain the notion of cost of illness, examining how it could be applied in such a framework. Then, an overview of the studies aimed at measuring direct and indirect costs of migraine and headache disorders will be carried out, later shifting on to the relationship between costs and quality of life for people affected by headache disorders.
As it has been seen, there are still many unsolved problems in disease costing, to the point that it still appears as a set of method that may lead to extremely different outcomes depending on the evaluation approach being used. Moreover, given the social relevance of migraine, together with the assessment of therapeutic options, it is important to increase the knowledge related to the economic consequences of prevention. From the analysis of prevalence, incidence, morbidity and the state of health caused by headache, it is important to stimulate the scientific community and policy makers to analyze the problems connected to the economic costs of headache. Costs of headache could be contained by observing their trends implementing specific “observatories”.
Overall, the bottom-up approach, applied in the Eurolight study, would seem the preferable and most comprehensive method to assess the societal burden of headache. However, a crucial factor is the attainment of a higher participation to the survey.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://​creativecommons.​org/​licenses/​by/​4.​0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Solomon GD, Price KL: Burden of migraine. A review of its socioeconomic impact. Pharmacoeconomics. 1997, 11 (Suppl 1): 1-10.CrossRefPubMed Solomon GD, Price KL: Burden of migraine. A review of its socioeconomic impact. Pharmacoeconomics. 1997, 11 (Suppl 1): 1-10.CrossRefPubMed
Metadaten
Titel
The costs of headache disorders
verfasst von
Francesco Saverio Mennini
Lara Gitto
Publikationsdatum
01.12.2015
Verlag
Springer Milan
Erschienen in
The Journal of Headache and Pain / Ausgabe Sonderheft 1/2015
Print ISSN: 1129-2369
Elektronische ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-16-S1-A3

Weitere Artikel der Sonderheft 1/2015

The Journal of Headache and Pain 1/2015 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.